Freya Pharma Solutions

Freya Pharma Solutions is a biotechnology company in the late clinical stage of pharmaceuticals, focusing on developing effective drug therapies for women diagnosed with Female Sexual Interest/Arousal Disorder (FSIAD). Established with the aim to build upon over fifteen years of research into two drug compounds, Lybrido and Lybridos, Freya is advancing these therapies to address this recognized unmet medical need and make them available to patients suffering greatly due to FSIAD.